Latest News about MDXG
Recent news which mentions MDXG
BioStem Aims To Stay Ahead Of Competition Through Its Unique Processes And Versatile Offerings In Wound Healing
December 08, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
October 13, 2022
From Benzinga
Nikola, Bed Bath & Beyond And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
September 14, 2022
From Benzinga
Earnings Scheduled For August 2, 2022
August 02, 2022
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
86 Biggest Movers From Yesterday
November 04, 2021
From Benzinga
Earnings Scheduled For November 2, 2021
November 02, 2021
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 14, 2021
From Benzinga
72 Biggest Movers From Yesterday
September 14, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Rises Over 100 Points; Itamar Medical Shares Spike Higher
September 13, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 13, 2021
From Benzinga
Mid-Day Market Update: Crude Oil Up 1%; MiMedx Group Shares Plummet
September 13, 2021
From Benzinga
45 Stocks Moving In Monday's Mid-Day Session
September 13, 2021
From Benzinga
Mid-Morning Market Update: Markets Mixed; UK Terminates Valneva's COVID-19 Vaccine Contract
September 13, 2021
From Benzinga
Mimedx Stock Plunges After Disappointing Data From Musculoskeletal Trials
September 13, 2021
Tickers
MDXG
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 13, 2021
From Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
From Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
From Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.